NCT07408310 Trial of Spiritual Care Interventions for Patients With Cancer
| NCT ID | NCT07408310 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Advanced Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 288 participants |
| Start Date | 2026-03-24 |
| Primary Completion | 2029-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 288 participants in total. It began in 2026-03-24 with a primary completion date of 2029-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to determine the effects of 2 spiritual care interventions. Spiritual wellness and healthcare service utilization will be measured from a sample of advanced cancer patients recruited from outpatient settings.
Eligibility Criteria
1. Diagnosed with an advanced cancer. 2. Member of a religious faith community organization. 3. Fluent in English. Exclusion Criteria: 1. Received spiritual care from a healthcare chaplain within the past 2 months. 2. Too weak or cognitively impaired to engage in study activities.
Contact & Investigator
Paul K Maciejewski, Ph.D.
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT07408310 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Advanced Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07408310 currently recruiting?
Yes, NCT07408310 is actively recruiting participants. Contact the research team at mkp4005@med.cornell.edu for enrollment information.
Where is the NCT07408310 trial being conducted?
This trial is being conducted at New York, United States, Galveston, United States, Houston, United States.
Who is sponsoring the NCT07408310 clinical trial?
NCT07408310 is sponsored by Weill Medical College of Cornell University. The principal investigator is Paul K Maciejewski, Ph.D. at Weill Medical College of Cornell University. The trial plans to enroll 288 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.